URGN: Urogen Pharma Ltd Financial Statements
Balance sheet, income statement, and cash flow statements for Urogen Pharma Ltd (URGN).
$449.42M Market Cap.
URGN Market Cap. (MRY)
URGN Shares Outstanding (MRY)
URGN Assets (MRY)
Total Assets
$285.71M
Total Liabilities
$294.51M
Total Investments
$69.90M
URGN Income (MRY)
Revenue
$90.40M
Net Income
-$126.87M
Operating Expense
$178.30M
URGN Cash Flow (MRY)
CF Operations
-$96.77M
CF Investing
-$20.61M
CF Financing
$194.62M
URGN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $285,711,000 (60.23%) | $178,311,000 (31.48%) | $135,619,000 (13.26%) | $119,746,000 (-1.85%) |
Assets Current | $276,135,000 (63.21%) | $169,186,000 (31.25%) | $128,907,000 (12.69%) | $114,390,000 (-1.06%) |
Assets Non-Current | $9,576,000 (4.94%) | $9,125,000 (35.95%) | $6,712,000 (25.32%) | $5,356,000 (-16.13%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$8,803,000 (86.50%) | -$65,212,000 (27.02%) | -$89,361,000 (-1162.18%) | $8,413,000 (-91.27%) |
Property Plant & Equipment Net | $3,789,000 (60.55%) | $2,360,000 (-37.05%) | $3,749,000 (19.13%) | $3,147,000 (-25.14%) |
Cash & Equivalents | $173,063,000 (80.61%) | $95,823,000 (70.44%) | $56,221,000 (23.33%) | $45,586,000 (-15.72%) |
Accumulated Other Comprehensive Income | $56,000 (366.67%) | $12,000 (111.21%) | -$107,000 (-328.00%) | -$25,000 (-109.23%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $69,896,000 (49.69%) | $46,693,000 (4.27%) | $44,779,000 (-1.97%) | $45,677,000 (-10.91%) |
Investments Current | $64,698,000 (54.17%) | $41,966,000 (-5.81%) | $44,556,000 (-0.50%) | $44,779,000 (-8.90%) |
Investments Non-Current | $5,198,000 (9.96%) | $4,727,000 (2019.73%) | $223,000 (-75.17%) | $898,000 (-57.56%) |
Inventory | $9,227,000 (62.65%) | $5,673,000 (31.17%) | $4,325,000 (-10.49%) | $4,832,000 (146.03%) |
Trade & Non-Trade Receivables | $20,302,000 (31.46%) | $15,443,000 (21.56%) | $12,704,000 (8.42%) | $11,717,000 (66.27%) |
Trade & Non-Trade Payables | $27,431,000 (65.87%) | $16,538,000 (33.55%) | $12,383,000 (2.32%) | $12,102,000 (20.74%) |
Accumulated Retained Earnings (Deficit) | -$806,222,000 (-18.68%) | -$679,348,000 (-17.72%) | -$577,104,000 (-23.49%) | -$467,321,000 (-31.09%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $3,791,000 (18.69%) | $3,194,000 (5.83%) | $3,018,000 (6.19%) | $2,842,000 (4.60%) |
Total Debt | $123,387,000 (24.14%) | $99,395,000 (0.27%) | $99,123,000 (24805.28%) | $398,000 (-73.41%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $123,387,000 (24.14%) | $99,395,000 (0.27%) | $99,123,000 (24805.28%) | $398,000 (-73.41%) |
Total Liabilities | $294,514,000 (20.94%) | $243,523,000 (8.24%) | $224,980,000 (102.08%) | $111,333,000 (334.05%) |
Liabilities Current | $45,949,000 (47.22%) | $31,212,000 (30.51%) | $23,916,000 (6.86%) | $22,380,000 (4.40%) |
Liabilities Non-Current | $248,565,000 (17.08%) | $212,311,000 (5.59%) | $201,064,000 (126.03%) | $88,953,000 (2010.89%) |
URGN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $90,398,000 (9.29%) | $82,713,000 (28.52%) | $64,357,000 (33.96%) | $48,042,000 (307.17%) |
Cost of Revenue | $8,881,000 (-5.13%) | $9,361,000 (22.30%) | $7,654,000 (48.42%) | $5,157,000 (411.10%) |
Selling General & Administrative Expense | $121,154,000 (29.89%) | $93,274,000 (12.60%) | $82,838,000 (-5.37%) | $87,535,000 (-2.97%) |
Research & Development Expense | $57,145,000 (25.28%) | $45,614,000 (-13.78%) | $52,906,000 (11.05%) | $47,642,000 (0.70%) |
Operating Expenses | $178,299,000 (28.38%) | $138,888,000 (2.32%) | $135,744,000 (0.42%) | $135,177,000 (-1.71%) |
Interest Expense | $12,521,000 (-14.91%) | $14,715,000 (74.39%) | $8,438,000 (0%) | $0 (0%) |
Income Tax Expense | $2,832,000 (-27.76%) | $3,920,000 (123.36%) | $1,755,000 (21.12%) | $1,449,000 (-57.05%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$126,874,000 (-24.09%) | -$102,244,000 (6.87%) | -$109,783,000 (0.94%) | -$110,820,000 (13.75%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$126,874,000 (-24.09%) | -$102,244,000 (6.87%) | -$109,783,000 (0.94%) | -$110,820,000 (13.75%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$126,874,000 (-24.09%) | -$102,244,000 (6.87%) | -$109,783,000 (0.94%) | -$110,820,000 (13.75%) |
Weighted Average Shares | $42,876,737 (48.70%) | $28,834,303 (26.43%) | $22,806,812 (2.06%) | $22,347,481 (2.60%) |
Weighted Average Shares Diluted | $42,876,737 (48.70%) | $28,834,303 (26.43%) | $22,806,812 (2.06%) | $22,347,481 (2.60%) |
Earning Before Interest & Taxes (EBIT) | -$111,521,000 (-33.38%) | -$83,609,000 (16.05%) | -$99,590,000 (8.94%) | -$109,371,000 (12.58%) |
Gross Profit | $81,517,000 (11.13%) | $73,352,000 (29.36%) | $56,703,000 (32.22%) | $42,885,000 (297.45%) |
Operating Income | -$96,782,000 (-47.68%) | -$65,536,000 (17.09%) | -$79,041,000 (14.36%) | -$92,292,000 (27.18%) |
URGN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$20,613,000 (-2062.96%) | -$953,000 (-189.91%) | $1,060,000 (-73.95%) | $4,069,000 (-95.64%) |
Net Cash Flow from Financing | $194,619,000 (66.44%) | $116,931,000 (20.38%) | $97,134,000 (34.31%) | $72,319,000 (337.58%) |
Net Cash Flow from Operations | -$96,766,000 (-26.70%) | -$76,376,000 (12.77%) | -$87,559,000 (-3.14%) | -$84,892,000 (19.83%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $77,240,000 (95.04%) | $39,602,000 (272.37%) | $10,635,000 (225.06%) | -$8,504,000 (-319.23%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$20,318,000 (-2576.94%) | -$759,000 (-157.76%) | $1,314,000 (-72.74%) | $4,821,000 (-94.90%) |
Capital Expenditure | -$295,000 (-52.06%) | -$194,000 (23.62%) | -$254,000 (66.22%) | -$752,000 (38.11%) |
Issuance (Repayment) of Debt Securities | $24,488,000 (0%) | $0 (0%) | $95,783,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $170,131,000 (45.50%) | $116,931,000 (7638.65%) | $1,511,000 (2377.05%) | $61,000 (-99.63%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $13,108,000 (40.30%) | $9,343,000 (-11.69%) | $10,580,000 (-54.22%) | $23,113,000 (-17.53%) |
Depreciation Amortization & Accretion | $1,186,000 (-30.44%) | $1,705,000 (-6.16%) | $1,817,000 (2.48%) | $1,773,000 (-13.26%) |
URGN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 90.20% (1.69%) | 88.70% (0.68%) | 88.10% (-1.34%) | 89.30% (-2.30%) |
Profit Margin | -140.40% (-13.59%) | -123.60% (27.55%) | -170.60% (26.05%) | -230.70% (78.81%) |
EBITDA Margin | -122.10% (-23.33%) | -99.00% (34.83%) | -151.90% (32.19%) | -224.00% (78.52%) |
Return on Average Equity (ROAE) | -7363.60% (-6622.23%) | 112.90% (-45.85%) | 208.50% (181.22%) | -256.70% (-154.66%) |
Return on Average Assets (ROAA) | -47.40% (32.77%) | -70.50% (7.48%) | -76.20% (13.11%) | -87.70% (-0.69%) |
Return on Sales (ROS) | -123.40% (-22.06%) | -101.10% (34.65%) | -154.70% (32.06%) | -227.70% (78.52%) |
Return on Invested Capital (ROIC) | -61.90% (-10.14%) | -56.20% (23.95%) | -73.90% (62.51%) | -197.10% (-50.69%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.6 (14.84%) | -4.22 (-129.12%) | -1.84 (3.81%) | -1.92 (37.23%) |
Price to Sales Ratio (P/S) | 5.05 (-3.40%) | 5.23 (66.37%) | 3.14 (-28.96%) | 4.42 (-86.70%) |
Price to Book Ratio (P/B) | -51.05 (-619.06%) | -7.1 (-209.77%) | -2.29 (-109.04%) | 25.34 (513.36%) |
Debt to Equity Ratio (D/E) | -33.46 (-795.98%) | -3.73 (-48.29%) | -2.52 (-119.03%) | 13.23 (4874.81%) |
Earnings Per Share (EPS) | -2.96 (16.62%) | -3.55 (26.20%) | -4.81 (3.02%) | -4.96 (15.93%) |
Sales Per Share (SPS) | 2.11 (-26.52%) | 2.87 (1.67%) | 2.82 (31.26%) | 2.15 (296.68%) |
Free Cash Flow Per Share (FCFPS) | -2.26 (14.76%) | -2.66 (31.01%) | -3.85 (-0.47%) | -3.83 (22.07%) |
Book Value Per Share (BVPS) | -0.2 (90.94%) | -2.26 (42.27%) | -3.92 (-1142.02%) | 0.38 (-91.50%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.66 (7.76%) | 6.18 (4.00%) | 5.95 (10.97%) | 5.36 (-4.34%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (20.00%) | -5 (-66.67%) | -3 (-200.00%) | -1 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.04 (25.29%) | -5.4 (-112.09%) | -2.55 (-74.21%) | -1.46 (51.91%) |
Asset Turnover | 0.34 (-40.70%) | 0.57 (27.52%) | 0.45 (17.63%) | 0.38 (375.00%) |
Current Ratio | 6.01 (10.87%) | 5.42 (0.58%) | 5.39 (5.46%) | 5.11 (-5.25%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$97,061,000 (-26.76%) | -$76,570,000 (12.80%) | -$87,813,000 (-2.53%) | -$85,644,000 (20.03%) |
Enterprise Value (EV) | $445,355,759 (0.66%) | $442,416,800 (77.65%) | $249,036,646 (58.35%) | $157,270,291 (-57.96%) |
Earnings Before Tax (EBT) | -$124,042,000 (-26.16%) | -$98,324,000 (8.98%) | -$108,028,000 (1.23%) | -$109,371,000 (12.58%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$110,335,000 (-34.71%) | -$81,904,000 (16.23%) | -$97,773,000 (9.13%) | -$107,598,000 (12.57%) |
Invested Capital | $190,086,000 (26.16%) | $150,671,000 (-2.54%) | $154,605,000 (196.30%) | $52,178,000 (8.76%) |
Working Capital | $230,186,000 (66.83%) | $137,974,000 (31.42%) | $104,991,000 (14.11%) | $92,010,000 (-2.31%) |
Tangible Asset Value | $285,711,000 (60.23%) | $178,311,000 (31.48%) | $135,619,000 (13.26%) | $119,746,000 (-1.85%) |
Market Capitalization | $449,423,759 (-2.93%) | $462,994,800 (126.06%) | $204,808,646 (-3.94%) | $213,217,291 (-46.44%) |
Average Equity | $1,723,000 (101.90%) | -$90,548,250 (-71.95%) | -$52,658,500 (-221.96%) | $43,178,000 (-66.13%) |
Average Assets | $267,519,250 (84.41%) | $145,064,750 (0.75%) | $143,987,000 (13.93%) | $126,382,750 (-14.30%) |
Invested Capital Average | $180,110,000 (21.12%) | $148,701,500 (10.27%) | $134,846,750 (142.96%) | $55,502,000 (-41.97%) |
Shares | 42,199,414 (36.72%) | 30,866,320 (33.68%) | 23,090,039 (2.99%) | 22,420,325 (1.48%) |
